Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1NIH 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 51Lung Neoplasms 32Lymphoma 31Breast Neoplasms 29Multiple Myeloma 27Prostatic Neoplasms 25Melanoma 23Carcinoma, Non-Small-Cell Lung 23Leukemia, Myeloid, Acute 22Neoplasm Metastasis 21Ovarian Neoplasms 20Lymphoma, Non-Hodgkin 20Hematologic Neoplasms 20Glioma 18Pancreatic Neoplasms 17Urinary Bladder Neoplasms 16Neuroblastoma 15Colorectal Neoplasms 15Burkitt Lymphoma 15Carcinoma, Renal Cell 14Sarcoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colonic Neoplasms 13Leukemia, Lymphocytic, Chronic, B-Cell 12Carcinoma 12Brain Neoplasms 12Triple Negative Breast Neoplasms 11Stomach Neoplasms 11Squamous Cell Carcinoma of Head and Neck 11Oropharyngeal Neoplasms 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Metabolic Syndrome × 30 days × Clear all
NCT01143480 2026-06-01

Study of the Effect of Innate on the Inflammatory Response to Endotoxin

National Institutes of Health Clinical Center (CC)

Recruiting
725 enrolled

Asthma, Insulin Resistance, Neoplasms, Metabolic Syndrome, Atherosclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡